In his latest off-label use-related law review article in 2021, Bexis pointed out: [A]lthough states have traditionally been recognized to have broad authority to regulate the practice of medicine, aside from occasional attempts to restrict use of abortifacients, state-law interventions restricting the off-label uses of prescription medical products have been infrequent. James M. Beck, “Off-Label... Continue Reading
